XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Schedule of Disaggregation of Revenue by Major Source
The following table disaggregates our revenue by major source (in millions):
 Three Months Ended September 30,Nine Months Ended September 30,
 2023202220232022
Automotive sales$18,582 $17,785 $57,879 $46,969 
Automotive regulatory credits554 286 1,357 1,309 
Energy generation and storage sales1,416 966 4,188 2,186 
Services and other2,166 1,645 6,153 4,390 
Total revenues from sales and services22,718 20,682 69,577 54,854 
Automotive leasing489 621 1,620 1,877 
Energy generation and storage leasing143 151 409 413 
Total revenues$23,350 $21,454 $71,606 $57,144 
Lease Receivables Relating to Sales-Type Lease
Lease receivables relating to sales-type leases are presented on the consolidated balance sheets as follows (in millions):
 September 30, 2023December 31, 2022
Gross lease receivables$803 $837 
Unearned interest income(84)(95)
Allowance for expected credit losses(6)(4)
Net investment in sales-type leases$713 $738 
Reported as:
Prepaid expenses and other current assets$178 $164 
Other non-current assets535 574 
Net investment in sales-type leases$713 $738 
Schedule of Reconciliation of Net Income Used in Computing Basic and Diluted Net Income Per Share of Common Stock and Basic to Diluted Weighted Average Shares Used in Computing Net Income Per Share of Common Stock
The following table presents the reconciliation of net income attributable to common stockholders to net income used in computing basic and diluted net income per share of common stock (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Net income attributable to common stockholders$1,853 $3,292 $7,069 $8,869 
Less: Buy-out of noncontrolling interest— (3)
Net income used in computing basic net income per share of common stock1,851 3,292 7,072 8,861 
Less: Dilutive convertible debt(0)(0)(0)(1)
Net income used in computing diluted net income per share of common stock$1,851 $3,292 $7,072 $8,862 
The following table presents the reconciliation of basic to diluted weighted average shares used in computing net income per share of common stock attributable to common stockholders (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Weighted average shares used in computing net income per share of common stock, basic3,1763,1463,1713,120
Add:
Stock-based awards304301297311
Convertible senior notes2224
Warrants11191139
Weighted average shares used in computing net income per share of common stock, diluted3,4933,4683,4813,474
Schedule of Potentially Dilutive Shares that were Excluded from Computation of Diluted Net Income per Share of Common Stock
The following table presents the potentially dilutive shares that were excluded from the computation of diluted net income per share of common stock attributable to common stockholders, because their effect was anti-dilutive (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Stock-based awards133123
Schedule of Cash and Cash Equivalents and Restricted Cash
Our total cash and cash equivalents and restricted cash, as presented in the consolidated statements of cash flows, was as follows (in millions):
 September 30,
2023
December 31,
2022
September 30,
2022
December 31,
2021
Cash and cash equivalents$15,932 $16,253 $19,532 $17,576 
Restricted cash included in prepaid expenses and other current assets453 294 382 345 
Restricted cash included in other non-current assets205 377 235 223 
Total as presented in the consolidated statements of cash flows$16,590 $16,924 $20,149 $18,144 
Schedule of Accrued Warranty Activity
Accrued warranty activity consisted of the following (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Accrued warranty—beginning of period$4,465 $2,433 $3,505 $2,101 
Warranty costs incurred(335)(236)(911)(574)
Net changes in liability for pre-existing warranties, including expirations and foreign exchange impact15 156 426 158 
Provision for warranty577 418 1,702 1,086 
Accrued warranty—end of period$4,722 $2,771 $4,722 $2,771